Wirksamkeit eines Sabal-Urtica-Kombinationspräparats bei der Behandlung der benignen Prostatahyperplasie (BPH)
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s001310050033.pdf
Reference37 articles.
1. Sökeland J (1993) Urologie, 11. Aufl. Thieme, Stuttgart, S 255–256
2. Roos NP, Wennberg JE, Malenka DJ et al. (1989) Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyper-plasia. N Engl J Med 320: 1120–1124
3. Doll HA, Black NA, McPherson K et al. (1992) Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol 147: 1566–1573
4. Sultan C, Terraza A, Devillier C et al. (1984) Inhibition of androgen metabolism and binding by a liposterolic extract of „Serenoa repens B” in human foreskin fibroblasts. J Steroid Biochem 20: 515–519
5. Düker EM, Kopanski L, Schweikert HU (1989) Inhibition of 5α-reductase activity by extracts from Sabal serrulata. Planta Med 55: 587
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of a proprietary mixture of extracts from Sabal serrulata fruits and Urtica dioica roots (WS® 1541) on prostate hyperplasia and inflammation in rats and human cells;Frontiers in Pharmacology;2024-03-15
2. Serenoa repens for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement: An Updated Cochrane Review;The World Journal of Men's Health;2024
3. Natural Products in the Treatment of Lower Urinary Tract Dysfunction and Infection;Handbook of Experimental Pharmacology;2024
4. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement;Cochrane Database of Systematic Reviews;2023-06-22
5. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis;Investigative and Clinical Urology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3